Protecting Biotech Innovation: Patent Insights | Matt Bresnahan
In this episode of Good Medicine, Dr. David Bearss sits down with Matt Bresnahan, a partner at Wilson Sonsini Goodrich & Rosati, to demystify the world of patents in biotech and life sciences. Togethe...
22 Jul 202559min
How Australia Is Reshaping Clinical Trials | Daniel Evans
Dr. David Bearss sits down with Daniel Evans of Southern Star Research to explore how Australia is becoming a global leader in Phase 1 clinical trials. They discuss how the country’s streamlined regul...
15 Jul 202543min
The Obesity Crisis & GLP-1 Drugs | A Candid Conversation Between Brothers
On this episode of Good Medicine, Dr. David Bearss sits down with his brother Jeremiah for a raw and insightful conversation about obesity, weight loss, and the explosive rise of GLP-1 drugs.Together,...
8 Jul 202551min
Vocal Biomarkers & Disease Detection | Henry O'Connell
This week on Good Medicine, we sit down with Henry O’Connell, CEO of Canary Speech, a company using vocal biomarkers to revolutionize mental and neurological health diagnostics.With a career spanning ...
1 Jul 20251h 2min
Founding Scientia and What Drives Him | John Lippert
In this episode of Good Medicine, David Bearss sits down with John Lippert, founder and Chief Technology Officer at Scientia. With a career spanning decades in the medical device industry, John shares...
24 Jun 202557min
Medical Devices & Strokes | Mark Paul
In this episode of Good Medicine, Dr. Bearss sits down with Mark Paul, a veteran of the medical device industry, to explore the intersection of innovation, engineering, and patient care.Mark shares le...
17 Jun 202559min
The FDA and NIH: What Works, What Doesn’t | Dr. David Bearss
This week on Good Medicine, Dr. David Bearss dives into the roles of the FDA and NIH in today’s healthcare landscape. He explores the vital impact these institutions have on innovation, safety, and pu...
10 Jun 202531min
Neurodegenerative Disease Research | Dr. Ryan Watts
In this episode of Good Medicine, Dr. Bearss sits down with Dr. Ryan Watts, CEO of Denali Therapeutics, to explore the cutting edge of neurodegenerative disease research.They dive deep into the scienc...
3 Jun 202544min
